47 results on '"Funazo, Tomoko"'
Search Results
2. Supplementary Data S1 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in EGFR Mutation–positive Lung Cancer
3. Supplementary Figure S10 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in EGFR Mutation–positive Lung Cancer
4. Supplementary Table S6 from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in EGFR Mutation–positive Lung Cancer
5. Data from Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in EGFR Mutation–positive Lung Cancer
6. Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in EGFR Mutation–positive Lung Cancer
7. Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer
8. CD47 polymorphism for predicting nivolumab benefit in patients with advanced non‑small‑cell lung cancer
9. Data from Acquired Resistance to Alectinib in ALK-Rearranged Lung Cancer due to ABCC11/MRP8 Overexpression in a Clinically Paired Resistance Model
10. Supplemental Legends from Alectinib Resistance in ALK-Rearranged Lung Cancer by Dual Salvage Signaling in a Clinically Paired Resistance Model
11. Data File S1 from Alectinib Resistance in ALK-Rearranged Lung Cancer by Dual Salvage Signaling in a Clinically Paired Resistance Model
12. Supplementary file 2 from Acquired Resistance to Alectinib in ALK-Rearranged Lung Cancer due to ABCC11/MRP8 Overexpression in a Clinically Paired Resistance Model
13. Data from Alectinib Resistance in ALK-Rearranged Lung Cancer by Dual Salvage Signaling in a Clinically Paired Resistance Model
14. Supplementary materials from Alectinib Resistance in ALK-Rearranged Lung Cancer by Dual Salvage Signaling in a Clinically Paired Resistance Model
15. Supplementary Data from Acquired Resistance to Alectinib in ALK-Rearranged Lung Cancer due to ABCC11/MRP8 Overexpression in a Clinically Paired Resistance Model
16. MCL1 inhibition is effective against a subset of small-cell lung cancer with high MCL1 and low BCL-XL expression
17. YAP1 mediates survival of ALK-rearranged lung cancer cells treated with alectinib via pro-apoptotic protein regulation
18. Clinical impact of low serum free T4 in patients with non-small cell lung cancer treated with nivolumab
19. Yes‐associated protein 1 mediates initial cell survival during lorlatinib treatment through AKT signaling in ROS1 ‐rearranged lung cancer
20. Sarcomatoid malignant pleural mesothelioma treated with nivolumab: A case series
21. Abstract 5335: Elucidation of initial resistance mechanisms in EGFR mutation-positive lung cancer focusing on YAP1 and cancer stem cells
22. Abstract 1601: CD47 related to intratumor heterogeneity in alectinib-resistant ALK-rearranged lung cancer cell lines
23. Liver Metastasis Is Associated with Poor Progression-Free Survival in Patients with Non–Small Cell Lung Cancer Treated with Nivolumab
24. Yes‐associated protein 1 mediates initial cell survival during lorlatinib treatment through AKT signaling in ROS1‐rearranged lung cancer.
25. Clinical Impact of Single Nucleotide Polymorphism in PD-L1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients
26. Abstract 1098: Activation of YAP1 confers ROS1 inhibitor resistance in ROS1-rearranged lung cancer
27. PD-L1 polymorphisms predict survival outcomes in advanced non-small-cell lung cancer patients treated with PD-1 blockade
28. ALK陽性肺がんにおけるアレクチニブ耐性は、ABCC11/MRP8過剰発現によってもたらされる-臨床由来ペア耐性モデルを用いた検討
29. Abstract 2728: Novel in vivo imaging method to evaluate “Don't eat me” signal of tumor against microglia
30. Acquired Resistance to Alectinib in ALK-Rearranged Lung Cancer due to ABCC11/MRP8 Overexpression in a Clinically Paired Resistance Model
31. Abstract 72: YAP1 mediates initial survival of alectinib therapy in ALK-rearranged lung cancer via pro-apoptotic protein regulation
32. Abstract 1271: ABCC11 is involved in resistance to alectinib
33. Alectinib Resistance in ALK-Rearranged Lung Cancer by Dual Salvage Signaling in a Clinically Paired Resistance Model
34. Abstract 2604: PD-L1 rs2282055 is associated with opposite treatment effect between platinum-based chemotherapy and nivolumab treatment
35. Abstract 295: Efficacy of MCL1 inhibitor S63845 in small cell lung cancer
36. Abstract 5541: Clinical impact of hypothyroidism and PD-L1 SNPs in patients having non-small cell lung cancer treated with nivolumab
37. Abstract 1830: A clinical paired resistant model elucidated novel dual salvage signaling that confers alectinib resistance in ALK-rearranged lung cancer
38. Retrospective analysis of acute exacerbation of interstitial lung diseases with nanoparticle albumin-bound paclitaxel in patients with advanced lung cancer with preexisting interstitial lung disease
39. Abstract 4161: Increased expression of ABCB1 could be associated with osimertinib resistance in non-small cell lung cancer cell line PC9 cell
40. Abstract 5736: Clinical impact of high serum hepatocyte growth factor in advanced non-small cell lung cancer
41. Successful oral desensitization with crizotinib after crizotinib‑induced hepatitis in an anaplastic lymphoma kinase‑rearranged non‑small‑cell lung cancer patient: A case report
42. Clinical impact of high serum hepatocyte growth factor in advanced non-small cell lung cancer
43. Successful Treatment with Alectinib for Choroidal Metastasis in Anaplastic Lymphoma Kinase Rearranged Non-small Cell Lung Cancer
44. Varicella Reinfection with Unilateral Varicella Pneumonia
45. Prolonged Disturbance of Consciousness Caused by Severe Hypophosphatemia: A Report of Two Cases
46. Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in EGFR Mutation-positive Lung Cancer.
47. EGFR T790M Detection in Circulating Tumor DNA from Non-small Cell Lung Cancer Patients Using the PNA-LNA Clamp Method.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.